Filociclovir (EP3934759A1) for Adenovirus Infection Treatment

The European Patent Office granted patent EP3934759A1 for Filociclovir, a pharmaceutical compound for treating adenovirus infections. The patent names Microbiotix, Inc. and The UAB Research Foundation as applicants, with Terry L. Bowlin and Mark N. Prichard as inventors. Designated states include EU member states and related European countries.

Affected parties should monitor this patent grant for potential licensing opportunities or freedom-to-operate implications. Competitors developing antiviral therapeutics may face patent infringement risks if their products fall within the scope of these claims.